WallStSmart

Cameco Corp (CCJ)vsUranium Royalty Corp (UROY)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Cameco Corp generates 6379% more annual revenue ($3.54B vs $54.60M). CCJ leads profitability with a 18.4% profit margin vs 8.0%. UROY trades at a lower P/E of 98.7x. CCJ earns a higher WallStSmart Score of 55/100 (C-).

CCJ

Buy

55

out of 100

Grade: C-

Growth: 8.7Profit: 7.0Value: 3.7Quality: 8.5
Piotroski: 5/9Altman Z: 2.42

UROY

Buy

54

out of 100

Grade: C-

Growth: 8.0Profit: 5.5Value: 4.0Quality: 8.5
Piotroski: 2/9Altman Z: 151.37

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCJ3 strengths · Avg: 9.3/10
EPS GrowthGrowth
87.5%10/10

Earnings expanding 87.5% YoY

Market CapQuality
$52.49B9/10

Large-cap with strong market position

Debt/EquityHealth
0.149/10

Conservative balance sheet, low leverage

UROY5 strengths · Avg: 9.6/10
Revenue GrowthGrowth
416400.0%10/10

Revenue surging 416400.0% year-over-year

EPS GrowthGrowth
462.2%10/10

Earnings expanding 462.2% YoY

Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
151.3710/10

Safe zone — low bankruptcy risk

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

Areas to Watch

CCJ4 concerns · Avg: 3.0/10
PEG RatioValuation
1.924/10

Expensive relative to growth rate

Price/BookValuation
8.8x4/10

Trading at 8.8x book value

P/E RatioValuation
111.6x2/10

Premium valuation, high expectations priced in

Free Cash FlowQuality
$-100.02M2/10

Negative free cash flow — burning cash

UROY4 concerns · Avg: 2.8/10
Market CapQuality
$433.91M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
1.1%3/10

ROE of 1.1% — below average capital efficiency

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

P/E RatioValuation
98.7x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : CCJ

The strongest argument for CCJ centers on EPS Growth, Market Cap, Debt/Equity. Profitability is solid with margins at 18.4% and operating margin at 18.2%.

Bull Case : UROY

The strongest argument for UROY centers on Revenue Growth, EPS Growth, Debt/Equity. Revenue growth of 416400.0% demonstrates continued momentum.

Bear Case : CCJ

The primary concerns for CCJ are PEG Ratio, Price/Book, P/E Ratio. A P/E of 111.6x leaves little room for execution misses.

Bear Case : UROY

The primary concerns for UROY are Market Cap, Return on Equity, Piotroski F-Score. A P/E of 98.7x leaves little room for execution misses.

Key Dynamics to Monitor

CCJ profiles as a mature stock while UROY is a hypergrowth play — different risk/reward profiles.

UROY carries more volatility with a beta of 1.75 — expect wider price swings.

UROY is growing revenue faster at 416400.0% — sustainability is the question.

UROY generates stronger free cash flow (9M), providing more financial flexibility.

Bottom Line

CCJ scores higher overall (55/100 vs 54/100), backed by strong 18.4% margins. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cameco Corp

ENERGY · URANIUM · USA

Cameco Corporation produces and sells uranium. The company is headquartered in Saskatoon, Canada.

Visit Website →

Uranium Royalty Corp

ENERGY · URANIUM · USA

Uranium Royalty Corp. The company is headquartered in Vancouver, Canada.

Visit Website →

Want to dig deeper into these stocks?